Change in treatment paradigm for DME with faricimab: Evidence from clinical trials and real-world practice
5 October, 13:30 – 14:30 CEST
Forum
Chairperson(s):
R. Tadayoni FRANCE
Satellite Symposia
The future of retinal care to meet the growing demand
6 October, 09:45 - 10:45 CEST
E102
Chairperson(s):
R.Guymer AUSTRALIA
Eye to Eye - Maximize your Surgical Approach
6 October, 09:45 - 10:45 CEST
Elicium 1
Chairperson(s):
R. Tadayoni FRANCE
Current management of inherited retinal diseases: the X-linked retinitis pigmentosa perspective
6 October, 09:45 - 10:45 CEST
Emerald Room
Chairperson(s):
B. Leroy BELGIUM
Have we maximised patient outcomes, or can we go further?
6 October, 09:45 - 10:45 CEST
Forum
Chairperson(s):
C. Wykoff USA
Modern imaging and algorithms for interrogating chorioretinal disease
6 October, 13:45 - 14:45 CEST
E103/104
Chairperson(s):
N. Waheed USA
Exploring Diabetic Macular Edema: Clinical Considerations and Perspectives on its Management
6 October, 13:45 - 14:45 CEST
Elicium 1
Chairperson(s):
R. Tadayoni FRANCE
Informed decision-making every step of the way - PART 1 : Diagnostic imaging in disease management
6 October, 13:45 - 14:45 CEST
E102
Chairperson(s):
J.F. Korobelnik FRANCE
Change in treatment paradigm for nAMD with faricimab: Evidence from clinical trials and real-world practice
6 October, 13:45 - 14:45 CEST
Auditorium
Chairperson(s):
F.G Holz GERMANY
Advances in Ultra-widefield Multimodal Retinal Imaging - Learn from our Experts
6 October, 13:45 - 14:45 CEST
Emerald Room
Chairperson(s):
S. Sadda USA
The future of continuous drug delivery for retinal diseases
6 October, 17.45 - 18.45 CEST
E103/104
Chairperson(s):
J. Graff USA
Is sustained disease control the new benchmark for patient care?
7 October, 10:15 - 11:15 CEST
Forum
Chairperson(s):
C. Hoyng THE NETHERLANDS
Laser for retina and vitreous: All you need to know in 2023.
7 October, 10:15 - 11:15 CEST
Emerald Room
Chairperson(s):
Victor Chong UK
Informed decision-making every step of the way - Part 2: Visualization in vitreoretinal surgery
7 October, 10:15 - 11:15 CEST
E102
Chairperson(s):
J.F. Korobelnik FRANCE
Discovering ChANGe with Ang-2
7 October, 10:15 - 11:15 CEST
E103/104
Chairperson(s):
P. Schlottman ARGENTINA
IME: Dry AMD & GA IME Platform: Practical Considerations for GA Treatment
7 October, 10:15 - 11:15 CEST
Elicium 2
Chairperson(s):
A. Loewenstein ISRAEL,
R. Tadayoni FRANCE
Geographic Atrophy: Navigating to the future
7 October, 13:00 - 14:00 CEST
Elicium 2
Chairperson(s):
R. Tadayoni FRANCE
What is Bayer’s vision for the future of ophthalmology?
7 October, 13:00 - 14:00 CEST
Forum
Chairperson(s):
J.F Korobelnik FRANCE
New Dimensions in Visualization: Changing the Way You Look
7 October, 13:00 - 14:00 CEST
E103/104
Chairperson(s):
R. Rejdak POLAND
High-Resolution OCT in Retinal Disorders including atrophic AMD
7 October, 13:00 - 14:00 CEST
E102
Chairperson(s):
S. Schulz GERMANY
LIGHTSITE III Pivotal Trial 24-Month Analysis: Multiwavelength Valeda® Light Delivery System Treatment in Early/Intermediate Dry Age-Related Macular Degeneration Patients
7 October, 13:00 - 14:00 CEST
Emerald Room
Chairperson(s):
Q.D. Nguyen USA
Retinale® - EURETINA Kompakt
7 October, 18:00 - 19:00 CEST
E103/104
Chairperson(s):
N. Feltgen GERMANY
